Cross Road Medical Center Phrmcy is categorized under in Glennallen, AK .
Cross Road Medical Center Phrmcy was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a business, which does work in the B2C market, and is classified as a , under code number 4461100 by the NAICS.
If you are seeking more information, feel free to contact Joel Mendendorp, Chief Executive Officer at the company’s single location by writing to Mile 187 Glenn Highway, Glennallen, Alaska AK 99588 or by phoning (907) 822-3203. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Cross Road Medical Center Phrmcy |
| Contact Person: | Joel Mendendorp, Chief Executive Officer |
| Address: | Mile 187 Glenn Highway, Glennallen, Alaska 99588 |
| Phone Number: | (907) 822-3203 |
| Website Address: | crossroadmc.org |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | |
| SIC Code: | 5912 |
| NAICS Code: | 4461100 |
| Share This Business: |
Cross Road Medical Center Phrmcy was started in 0 to provide professional under the SIC code 5912 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Joel Mendendorp, Chief Executive Officer for inquiries that concern Cross Road Medical Center Phrmcy by calling the company number (907) 822-3203, as your correspondence is most welcome. Additionally, the physical location of the single location of Cross Road Medical Center Phrmcy can be found at the coordinates 62.1077,-145.52846 as well as the street address Mile 187 Glenn Highway in Glennallen, Alaska 99588.
For its online presence, you may visit Cross Road Medical Center Phrmcy’s website at crossroadmc.org and engage with its social media outlets through on Twitter and on Facebook.